Determining Cross-Contamination Risks in Multiproduct Biopharmaceutical Facilities

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2014
Volume 2014 eBook
Issue 2

A global contract manufacturer of biologics discusses the increasing impact of health-based exposure limits in assessing cross-contamination risks.

 

A global contract manufacturer of biologics discusses the increasing impact of health-based exposure limits in assessing cross-contamination risks.

Download

Pharmaceutical Technology’s 2014 Bioprocessing and Sterile Manufacturing eBook

.

 

 

 

 

 

 

 

Articles in this issue
Continious-Biopharma185.jpg
Potential Benefits Drive Interest in Continuous Manufacturing
stephaniedubois200.jpg
Continuous Bioprocessing Challenges
PTebook0514_Cross-Contamination185.jpg
Determining Cross-Contamination Risks in Multiproduct Biopharmaceutical Facilities
PTebook0514_Continuous-Monitoring_1851431659146699.jpg
Achieving and Maintaining Compliance Using Continuous Monitoring Systems
PTebook0514_Telstar185.jpg
Optimizing the Sterilization of Liquids in Sealed Containers
par-almhelm200.jpg
Using Modular Systems in Biopharmaceutical Manufacturing
PTebook_Genzyme185.jpg
Determining Protein Oxidation Induced During Fill-Finish Operations
PTebook0514_SingleUse_185.jpg
Single-Use Technology in Parenteral Fill/Finish
Recent Videos
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Jens Schmidt, associate director MSAT at Lonza
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content
Magnified View of Lipid Nanoparticles | Image Credit: ©Aniwat - stock.adobe.com

Organic Nanoparticle-Based Drug-Delivery Systems as Alternatives to Lipid Nanoparticles

Cynthia A. Challener
March 9th 2025
Article

Exosomes, polymeric nanoparticles, and DNA nanostructures offer many potential advantages.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Two dosing pens of a fictitious semaglutide drug (GLP-1) on a scale facing a dumbbell. Concept for alternative ways to loose weight. | Image Credit: © Andreas Prott - Stock.adobe.com

Next-Generation Anti-Obesity Medicines

Cheryl Barton
February 8th 2025
Article

European biopharma companies are looking beyond GLP-1s.

Drug Solutions Podcast: mRNA Past, Present, and Future

Drug Solutions Podcast: mRNA Past, Present, and Future

Chris Spivey
August 17th 2023
Podcast

An mRNA conversation about the recent past, current hot topics, and probable future.

Pile of colorful medicine pills and capsules in blister packs | Image Credit: © ImageFlow - stock.adobe.com

Meeting Secondary Packaging Challenges of Innovative Delivery Systems for Biologics

Joe Compton
February 6th 2025
Article

Rapid market growth in biologics is helping the packaging market expand as well, but the complex nature of biologics and the desire for personalized therapies present unique hurdles to make packaging solutions cost-effective and safe for patients.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

2025 Pharmapack Winners Showcase Innovations in Pharma Packaging and Drug Delivery

Feliza Mirasol
January 28th 2025
Article

Winners in this year's Pharmapack Awards include both commercial products and innovations that are shaping the future of pharmaceutical packaging.